Inventor · disambiguated record
Stephen Paul Arns
Also filed as: ARNS STEPHEN · ARNS STEPHEN PAUL
4 granted patents·9 pending applications·11 citations·filing 2012–2024
68Inventor score
Top patents by PatentIndex Score
13 records- 0191US12129223B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·4 cites·26 claims
- 0277US11279732B2Somatostatin receptor antagonist compounds and methods of using the sameCDRD VENTURES INC·Filed 2017·Granted Mar 22, 2022·5 cites·48 claims
- 0372US2025188020A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0464US9611284B2Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereofUNIV FRASER SIMON·Filed 2012·Granted Apr 4, 2017·2 cites·10 claims
- 0562US2024423915A1Lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0662US2024417370A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0761US2025025427A1Mixed amide ester containing lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0860US2024239790A17-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 0960US2024246960A17-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 1059US2025059131A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1157US12486302B2Somatostatin receptor antagonist compounds and methods of using the sameCDRD VENTURES INC·Filed 2021·Granted Dec 2, 2025·0 cites·53 claims
- 1257US2025092002A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1354US2025326754A1DNA-PK Inhibitor Compounds and Uses ThereofADMARE THERAPEUTICS SOC·Filed 2023·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →